BioSante Pharmaceuticals, Inc. (BPAX)

[izler]

Well it would appear there is something going on behind closed doors. Why would they continue to get rid of debt, when it is not really necessary atm. They already cut back positions to save money, converted shares previously to free up debt and really the only burn rate is Libigel from my understanding since GVAX has outside sources funding it if I remember correctly from listening to one of those meetings a while back. I hate to speculate, but why are they so concerned about freeing up debt that does not need to be paid yet? Why do they continue to sit around and withhold possible news releases that could boost the share price? They must have some news even if it's not on Libigel. None of this seems right. This company has so many drugs in their pipeline, one of the most articulate CEOs who obviously knows what he's doing since the previous companies he was apart of were bought out...but hey, this is BPAX. Maybe the manipulation will stop soon?